The FINANCIAL — The board of directors of Pfizer Inc. on December 14 declared a 30-cent first-quarter 2016 dividend on the company’s common stock, payable March 2, 2016, to shareholders of record at the close of business on February 5, 2016.
Pfizer increased the dividend by approximately 7 percent, to 30 cents from 28 cents per share, according to Pfizer.
The first-quarter 2016 cash dividend will be the 309th consecutive quarterly dividend paid by Pfizer.
“The dividend increase is a testament to our continued commitment to enhancing shareholder value and our confidence in the business,” stated Ian Read, Pfizer chairman and chief executive officer. “As always, we are focused on maximizing total shareholder return, of which the dividend remains a key component.”